Ball Tip Model 030-185
Med Telectronics
FDA Clearance Information
The ball tip model 030-185 was cleared by the FDA through the 510k pathway on February 24, 1977. It is manufactured by Med Telectronics and classified as a Class 3 device.
What It Is
FDA-Cleared Indications
- Prevention of pulmonary embolism by filtering thrombi from the inferior vena cava.
- Use in patients at risk for pulmonary embolism when anticoagulant therapy is contraindicated or cannot be used.
Clinical Applications
- Placement in the inferior vena cava to reduce the risk of pulmonary embolism.
- Use during an interventional vascular procedure for patients who cannot receive anticoagulation therapy.
- Use in selected patients with venous thromboembolism who remain at risk for pulmonary embolism despite limitations on anticoagulant treatment.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The available record does not provide the device's dimensions, delivery-system specifications, or compatible vessel-size range; these should be confirmed in the original labeling or device documentation.
- The record does not establish whether this device is MRI safe, MRI conditional, or MRI unsafe. MRI status should be verified with the manufacturer or original FDA labeling before scanning.
- IVC filter placement requires imaging guidance and assessment of the IVC and access vessels before deployment.
- Potential complications of IVC filters include access-site bleeding, filter migration, malposition, thrombosis, vessel injury, and filter-related perforation.
- The record does not specify whether the filter is permanent or retrievable. Removal should not be assumed unless the original labeling confirms retrievability.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for ball tip model 030-185?
The ball tip model 030-185 is indicated for use as an IVC filter to prevent pulmonary embolism in patients with contraindications to anticoagulation therapy.
What outcomes have been reported in clinical studies?
Clinical studies have reported high efficacy in preventing embolic events, with successful capture of blood clots in the IVC.
What complications have been reported?
Safety data from evidence indicate rare complications such as device migration and filter fracture, emphasizing the need for careful monitoring.